Companion Diagnostics Market Research Report by Classification System, by Component, by End User, by Region – Global Forecast to 2026

Market Research Engine has published a new report titled asCompanion Diagnostics Market Size, By Indication (Breast, Lung & Colorectal Cancer, Cardiovascular Disease), By Technology (PCR, NGS, ISH, IHC), By Product & Service (Assay, Kit, Software & Service) By End-User (Pharma Companies, CRO), By Region, Market Analysis Report, Forecast 2021-2026-Executive Data Report.’’

Browse Full Report:

The companion diagnostics market is expected to cross more than USD 6.8 billion by 2026 at a CAGR of 12.9%.

Global Companion Diagnostics market is segmented based on the Indication as, Breast, Lung & Colorectal Cancer, Cardiovascular Disease. On the basis of Technology, the global Companion Diagnostics market is segregated as NGS, PCR, IHC ISH. On the basis of Product & Service Assay, Software & Service, Assay The report segments global Companion Diagnostics market based on End-User as CRO, Pharma Companies.

This Companion Diagnostics market study offers a comprehensive analysis of the business models, key strategies, and respective market shares of a number of the foremost prominent players during this landscape. Alongside an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered within the full study. This study is one among the foremost comprehensive documentation that captures all the facets of the evolving Companion Diagnostics market. Such epidemic condition is being tailgated by the necessity of safe and effective and specific use of the drug. due to such demands, companion diagnostic drug market is poised for exponential growth. Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for his or her patients and is crucial for myriad of cancer and other therapies. Riding on the rear of economic burden of worldwide healthcare and with abundant potential to limit the liability, these are medical instruments that support doctors to elect which treatment and dosage should tend to patients personalized to their necessity. Companion Diagnostics is employed to determine who would enjoy treatment and it comes in handy to spot if someone can’t be cured, but also conversely are often harmed by use of specific drug used for his or her ailment. Technological advancements have brought tons of changes within the method of disease treatment. Companion diagnostics is characterized by growing requirement for enhanced personalized patient treatment that provides healthcare providers and their patients an assurance about the treatment end in a positive way, contrary to traditional treatment procedure. Major impact of companion diagnostic is going to be been on oncology therapy area.

Global Companion Diagnostics market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional Companion Diagnostics market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.

Research Methodology:

To calculate the market size, the report considers the revenue generated from the sales of Companion Diagnostics market manufacturers. The revenue generated from the sales of Companion Diagnostics manufacturer has been calculated through primary and secondary research.

The market size estimation also considered leading players revenues as part of triangulation The key players considered are F. Hoffmann-La Roche AG (Switzerland), Agilent Technologies, Inc. (US), QIAGEN N.V. (Germany), Abbott Laboratories, Inc. (US), Almac Group (UK), Danaher Corporation (US), Illumina, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc., (US), Sysmex Corporation (Japan), Thermo Fisher Scientific Inc. (US), Abnova Corporation (Taiwan), and Guardant Health, Inc. (US). in the Companion Diagnostics market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes types of segmentation determined using secondary sources and verified through primary sources.

The Companion Diagnostics Market has been segmented as below:

Companion Diagnostics Market, By Indication

Infectious Diseases Cardiovascular Diseases Neurological Diseases Cancer Others

Companion Diagnostics Market, By Technology          

Immunohistochemistry (IHC) in Situ Hybridization (ISH) Polymerase Chain Reaction (PCR) Next-Generation Sequencing (NGS) Other Technologies

Companion Diagnostics Market, By Product & Service

Software & Services Assays, Kits, & Reagents

Companion Diagnostics Market, By End-User

Contract Research Organizations Reference Laboratories Pharmaceutical & Biopharmaceutical Companies Other End Users

Companion Diagnostics Market, By Region

North America Europe Asia Pacific Rest of World

Report scope:

The global Companion Diagnostics market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends. The report scope includes market analysis on regional as well as country level.

Reasons to Buy this Report:

Gain comprehensive insights on the industry trends Identify industry opportunities and key growth segments Obtain complete market study on the Companion Diagnostics market

Request Sample Report from here:

 Table of Contents:

1.1.    Key Points
1.2.    Report Description
1.3.    Markets Covered
1.4.    Stakeholders
2.    Research Methodology
2.1.    Research Scope
2.2.    Market Research Process
2.3.    Research Data Analysis
2.3.1.    Secondary Research
2.3.2.    Primary Research
2.3.3.    Models for Estimation
2.4.    Market Size Estimation
2.4.1.    Bottom-Up Approach
2.4.2.    Top-Down Approach
3.    Executive Summary
4.    Companion Diagnostics Market, By Indication

4.1.    Key Points
4.2.    Infectious Diseases
4.2.1.    Market Overview
4.2.2.    Market Size & Forecast
4.3.    Cardiovascular Diseases
4.3.1.    Market Overview
4.3.2.    Market Size & Forecast
4.4.    Neurological Diseases
4.4.1.    Market Overview
4.4.2.    Market Size & Forecast
4.5.    Cancer
4.5.1.    Market Overview
4.5.2.    Market Size & Forecast
4.6.    Others
4.6.1.    Market Overview
4.6.2.    Market Size & Forecast
5.    Companion Diagnostics Market, By Technology
5.1.    Key Points
5.2.    Immunohistochemistry (IHC)
5.2.1.    Market Overview
5.2.2.    Market Size & Forecast
5.3.    in Situ Hybridization (ISH)
5.3.1.    Market Overview
5.3.2.    Market Size & Forecast
5.4.    Polymerase Chain Reaction (PCR)
5.4.1.    Market Overview
5.4.2.    Market Size & Forecast
5.5.    Next-Generation Sequencing (NGS)
5.5.1.    Market Overview
5.5.2.    Market Size & Forecast
5.6.    Other Technologies
5.6.1.    Market Overview
5.6.2.    Market Size & Forecast
6.    Companion Diagnostics Market, By Product & Service
6.1.    Key Points
6.2.    Software & Services
6.2.1.    Market Overview
6.2.2.    Market Size & Forecast
6.3.    Assays, Kits, & Reagents
6.3.1.    Market Overview
6.3.2.    Market Size & Forecast
7.    Companion Diagnostics Market, By End-User
7.1.    Key Points
7.2.    Contract Research Organizations
7.2.1.    Market Overview
7.2.2.    Market Size & Forecast
7.3.    Reference Laboratories
7.3.1.    Market Overview
7.3.2.    Market Size & Forecast
7.4.    Pharmaceutical & Biopharmaceutical Companies
7.4.1.    Market Overview
7.4.2.    Market Size & Forecast
7.5.    Other End Users
7.5.1.    Market Overview
7.5.2.    Market Size & Forecast
8.    Companion Diagnostics Market, By Region
8.1.    North America
8.1.1.    North America Industrial Floor Coating, By Indication
8.1.2.    North America Industrial Floor Coating, By Technology
8.1.3.    North America Industrial Floor Coating, By End-User
8.1.4.    North America Industrial Floor Coating, By Product & Service
8.1.5.    By Country    U.S    Canada    Mexico
8.2.    Europe
8.2.1.    Europe Industrial Floor Coating, By Indication
8.2.2.    Europe Industrial Floor Coating, By Technology
8.2.3.    Europe Industrial Floor Coating, By End-User
8.2.4.    Europe Industrial Floor Coating, By Product & Service
8.2.5.    By Country    U.K    Germany    Italy    France    Rest of Europe
8.3.    Asia Pacific
8.3.1.    Asia Pacific Industrial Floor Coating, By Indication
8.3.2.    Asia Pacific Industrial Floor Coating, By Technology
8.3.3.    Asia Pacific Industrial Floor Coating, By End-User
8.3.4.    Asia Pacific Industrial Floor Coating, By Product & Service
8.3.5.    By Country    China    Australia    Japan    South Korea    India    Rest of Asia Pacific
8.4.    Rest of World
8.4.1.    Rest of World Industrial Floor Coating, By Indication
8.4.2.    Rest of World Industrial Floor Coating, By Technology
8.4.3.    Rest of World Industrial Floor Coating, By End-User
8.4.4.    Rest of World Industrial Floor Coating, By Product & Service

Other Related Market News :

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay


Phone: +1-855-984-1862

Country: United States